Experimental Technologies in the Diagnosis and Treatment of COVID-19 in Patients with Comorbidities
- 15 September 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Healthcare Informatics Research
- Vol. 6 (1), 48-71
- https://doi.org/10.1007/s41666-021-00106-7
Abstract
The COVID-19 pandemic has impacted the whole world and raised concerns about its effects on different human organ systems. Early detection of COVID-19 may significantly increase the rate of survival; thus, it is critical that the disease is detected early. Emerging technologies have been used to prevent, diagnose, and manage COVID-19 among the populace in the USA and globally. Numerous studies have revealed the growing implementation of novel engineered systems during the intervention at various points of the disease’s pathogenesis, especially as it relates to comorbidities and complications related to cardiovascular and respiratory organ systems. In this review, we provide a succinct, but extensive, review of the pathogenesis of COVID-19, particularly as it relates to angiotensin-converting enzyme 2 (ACE2) as a viral entry point. This is followed by a comprehensive analysis of cardiovascular and respiratory comorbidities of COVID-19 and novel technologies that are used to diagnose and manage hospitalized patients. Continuous cardiorespiratory monitoring systems, novel machine learning algorithms for rapidly triaging patients, various imaging modalities, wearable immunosensors, hotspot tracking systems, and other emerging technologies are reviewed. COVID-19 effects on the immune system, associated inflammatory biomarkers, and innovative therapies are also assessed. Finally, with emphasis on the impact of wearable and non-wearable systems, this review highlights future technologies that could help diagnose, monitor, and mitigate disease progression. Technologies that account for an individual’s health conditions, comorbidities, and even socioeconomic factors can drastically reduce the high mortality seen among many COVID-19 patients, primarily via disease prevention, early detection, and pertinent management.Keywords
This publication has 114 references indexed in Scilit:
- Serum levels of RAAS components in COPDPublished by European Respiratory Society (ERS) ,2015
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012
- Socioeconomic inequalities in the diffusion of health technology: Uptake of coronary procedures as an exampleSocial Science & Medicine (1982), 2011
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2Journal of Virology, 2010
- Socioeconomic Disparities in Health in the United States: What the Patterns Tell UsAmerican Journal of Public Health, 2010
- Proteolytic Activation of the 1918 Influenza Virus HemagglutininJournal of Virology, 2009
- COPD is associated with increased mortality in patients with community-acquired pneumoniaEuropean Respiratory Journal, 2006
- Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with ReceptorScience, 2005
- The Novel Angiotensin-Converting Enzyme (ACE) Homolog, ACE2, Is Selectively Expressed by Adult Leydig Cells of the TestisEndocrinology, 2004
- ABC of Oxygen: Acute oxygen therapyBMJ, 1998